Objective: In this study, we aimed to explore prognostic importance of definition of preoperative metabolic tumor volume in esophageal cancer patients. Methods: 22 patients who have histologically proven stage IIA-III esophageal cancer and underwent 18 F-FDG PET/CT for preoperative staging of disease were included to the study. After F-FDG PET/CT for preoperative staging of esophageal cancer. Preoperative diagnosis was squamous cell and adeno cancer in 17 (%77) and 5 (%23) patients, respectively. Location of primary tumor is distal, proximal and mid-esophagus in 13 (%59), 6 (%27) and 3 (%13) patients, respectively. Primary tumor of all the patients were FDG avid (mean SUV max : 18.85±7.0; range: 5.5-35.1). Additionally, 18 F-FDG uptake was seen in mediastinal lymph nodes in 13 patients (5.45±8.15; range: 2.6-29.9). Mean metabolic tumor volumes of primary esophageal lesions were calculated as 8.77±8.46cm³ (range: 2.3-34.2). Mean MTV of lymph nodes was 2.44±1.01cm³ (range: 0.4-3.6). Mean total metabolic tumor volume was calculated as 9.99±8.58cm³ (range: 2.3-27.3). 10 patients died during 447±121 days follow-up period. Mean survival time was 11.9±1.5 months (95%CI: 8.99-14.74) for entire patient group. Total metabolic tumor volume had a significant effect on survival (p=0.045) according to Cox proportional hazards regression analysis. One unit increase in MTV caused 1.1 (95%CI:1.003-1.196) fold increase in hazard, at any time. Conclusion: Definition of preoperative metabolic tumor volume has a prognostic value in the prediction of postoperative survival times. Patients who have higher preoperative metabolic tumor volumes could be good candidates for more aggressive chemo-radiation therapy regiments.
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Introduction
Esophageal cancer is the eighth most common malignancy and one of the most common causes of cancer related mortality (1) . Disease prognosis is strongly related with stage at diagnosis, because for most patients diagnosed at late-stage of disease, 5 years survival has been reported to be less than 20% (2) . Resectability and overall prognosis depend on tumor stage and disease extent (3) .
Recently, metabolic tumor volume (MTV) measured by 18 F-FDG PET/CT has been described as a new prognostic factor in several tumors (4, 5, 6, 7) . Because of nonhomogeneous metabolic pattern of tumors, definition of metabolic tumor volume could be more valuable than measurement of maximum standardized uptake value (SUV max ).
In this study, we aimed to explore prognostic importance of preoperative metabolic tumor volume in stage IIA-III esophageal cancer patients.
Materials and Methods

Patients
This retrospective study was designed to search esophageal cancer patients who were referred for 
Discussion
Prediction of disease prognosis and survival in preoperative period is crucial for consideration of more aggressive pre or postoperative adjuvant treatments in selected esophageal cancer patients (8) .
18
F-FDG PET/ CT is a metabolic imaging method and its usefulness in esophageal cancer patients has been reported in several studies (9, 10, 11, 12) . SUV has been widely used parameter for evaluation of FDG uptake degree of several tumor types. However, because generally tumors have nonhomogeneous 18 F-FDG uptake pattern, SUV could be a rough parameter in the evaluation of total lesion glucose metabolism.
Recently, new studies focused on evaluation of tumor burden by metabolic tumor volume measurements instead of evaluation of SUV. It is reported that MTV is a prognostic factor for prediction of disease prognosis in several tumors (4, 5, 6, 7) . In this study we described the prognostic importance of delineation of preoperative MTV in esophageal cancer patients. We only included operable stage IIA-III patients for standardization of patients. In inoperable advanced stage patients, disease prognosis could be affected by several factors such as different chemo or radiation therapy protocols. Prognostic role of MTV might be explored in inoperable patients who took similar chemoradiation therapy regiments. However in this case delineation of MTVs might be practically impossible in patients who have multiple distant metastases.
Predictive value of 18 F-FDG PET/CT in the evaluation of regional lymph node metastases has been investigated by Hsu et al. (12) . They concluded that SUV max of extratumoral uptake and the number of PET abnormalities were significantly associated with N classification. I et al. have reported relationship between MTV and lymph node status in esophageal cancer patients (3). We investigated prognostic value of MTV in esophageal cancer patients. Because lymph node status and disease stage are strongly correlated with disease prognosis, results of our study are concordant with the literature. We found a statistically significant relationship between MTV and survival times. However we could not define a threshold for MTV to predict disease prognosis because of the limited number of patients. Larger and prospective new studies are needed to describe possible threshold for MTV in esophageal cancer. Preliminary results of this study might lead to establish new studies in this area.
Conclusion
Definition of preoperative MTV is a prognostic value in the prediction of postoperative survival times. Patients who have higher preoperative MTVs could be good candidates for more aggressive chemo-radiation therapy regiments.
